CNRS Research Director · Marseille
Dr. Jean-Marc
Sabatier
PhD & HDR · Biochemist · Toxinologist

Research Director at the CNRS, holder of a Ph.D. in Cell Biology & Microbiology and an HDR in Biochemistry. A specialist in animal toxins and microorganisms, and author of nearly 280 scientific articles and 55 patents, he works at the intersection of academic, industrial, and international research.

American Peptide Society · European Peptide Society · American Society for Microbiology · New York Academy of Sciences · Biochemical Society
Key Figures
~280
Published scientific articles
201
Scientific presentations
55
Patents in biology & chemistry
80
Journal editorial boards
36
Special issues & books
114
Journals for which he serves as a reviewer
IF 35
Maximum impact factor (reviewed journals)
1994
Citizen of the Year Award – Le Nouvel Économiste
Latest published books
Long COVID and Adverse Vaccine Effects: Biological Mechanisms and Promising Treatments

At the onset of the health crisis, as understanding of the coronavirus remained limited, a new reality emerged, extending beyond the initial acute infection.

Long COVID defies any simplistic explanation. Patients suffer from a variety of ailments: extreme fatigue, respiratory, cardiovascular, and gastrointestinal problems, neurological disorders, and more. And doctors are desperately searching for answers and therapeutic solutions.

Nothing escapes messenger RNA—humans, animals, plants: the contamination of all living things is underway

“Vaccination” is no longer a medical tool: it is a dogma. A global obsession in which science takes a back seat to belief. Once a bulwark against certain diseases, the “vaccine” has become the icon of blind technological progress, sanctified by politicians, industrialists, and the new high priests of medicine. Never mind the failures, the side effects, the broken promises: the injection is now the answer to everything.

Academic & Institutional Background
Current
Research Director — CNRS, France
Leading research teams at the CNRS, INSERM, and the University. Research focused on animal toxins and microorganisms.
Past
Director of the ERT62 Laboratory — Marseille, France
Led a joint academic-industrial laboratory dedicated to therapeutic peptide engineering (ERT62, Marseille). Collaboration between the CNRS, INSERM, the university, and the private sector.
Past
Research Director — French private companies & Canadian public company
Technology transfer and commercialization of research results in the industrial sector, in France and Canada.
Education & Academic Qualifications
HDR
Habilitation to Supervise Research (HDR) — Biochemistry
Highest French academic qualification authorizing the supervision of research.
PhD
Doctorate — Cell Biology & Microbiology

Ph.D. training in cell biology and microbiology, which forms the foundation of his work on toxins and pathogens.
Areas of Expertise & Research Focuses
Animal Toxins
Study of venoms and toxins of animal origin, their mechanisms of action on living organisms, and their therapeutic potential. Contributions to 36 special issues or books on toxinology.
Virology & Coronaviruses
Research on viruses and infectious agents, including coronaviruses. Editor of the “Coronaviruses” e-book series, an international reference in this field.
Therapeutic Peptides
Design and engineering of bioactive peptides for therapeutic use. Director of the specialized ERT62 laboratory, with 55 patents filed in biology and chemistry.
Antivirals
Recipient of the “Citizen of the Year” award from Le Nouvel Économiste (1994) for his pioneering work on antivirals, in recognition of the impact of his research on public health.
Scientific Publishing
Editor-in-chief of the *Journal of Current Toxicology and Venomics*, member of 80 editorial boards (with Impact Factors up to 23), reviewer for 114 international journals (with Impact Factors up to 35), and expert for national and international institutions.
Editorial Roles
Editor-in-Chief
Journal of Current Toxicology and Venomics

A leading international journal specializing in toxinology and venomics. Dr. Sabatier serves as its editor-in-chief, overseeing the selection and publication of the most advanced research in these disciplines.

Editor · E-book Series
Coronavirus

Editor-in-Chief of the international series of digital publications on coronaviruses, featuring contributions from the world’s leading experts in virology.

Section Editor-in-Chief & Associate Editor
Antibiotics · Journal of Advanced Research · Peptides · Molecules · Military Medical Research

Editorial responsibilities for several high-impact-factor journals, including Antibiotics (Section Editor-in-Chief) and Journal of Advanced Research (Associate Editor). Active member of 80 editorial boards of international scientific journals.

Publications & Presentations
✍
~280 scientific articles
Publications in leading international journals in biology, biochemistry, toxinology, and virology.
✍
201 scientific presentations
Presentations at national and international conferences in the fields of toxinology, therapeutic peptides, and virology.
✍
36 special issues or books
Coordination of and contributions to thematic issues and edited volumes in toxinology and virology.
⚗
55 patents
Protected innovations in biology and chemistry, particularly in the field of therapeutic peptides and antivirals.
Awards & Recognition
Award · 1994
“Citizen of the Year”
Awarded by Le Nouvel Économiste

Award presented by Le Nouvel Économiste in 1994 in recognition of his pioneering work on antivirals, highlighting the impact of his research on public health and its broader societal significance beyond the strictly academic sphere

Antiviral Drugs Public Health Scientific Innovation Applied Research
“Exploring the frontiers of life to better understand, prevent, and treat.”